TAYLOR HIGLEY: Open Payments
NPI 1912787029 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 9 payments from 6 companies in 2025. Trend: 2023 $129 · 2024 $405 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $68 |
| Janssen Biotech, Inc. | 1 | $33 |
| TerSera Therapeutics LLC | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VIBERZI, TREMFYA, Xermelo, IQIRVO, REZDIFFRA, RINVOQ, ENTYVIO, MAVYRET.
Industry payments across MT — which companies pay providers there.
